Farmas USA

Mis cadáveres en el ASH

CLDX

Celldex Presents Data on CDX-1140, a Novel CD40 Agonist Antibody for Hematologic and Solid Malignancies, at the American Society of Hematology (ASH) Annual Meeting

http://ir.celldex.com/releasedetail.cfm?ReleaseID=1002579

DVAX

Dynavax Presents Clinical Data from Lead Cancer Immunotherapy Candidate, SD-101, in Combination with Targeted Low-Dose Radiation, at ASH Annual Meeting

https://finance.yahoo.com/news/dynavax-presents-clinical-data-lead-120000739.html

CEMP
• Cempra (NASDAQ:CEMP) is up 8% premarket on modest volume in response to its announcement that licensee Toyama Chemical Co., Ltd., has initiated a Phase 3 study in Japan evaluating solithromycin compared to levofloxacin in patients with community-acquired bacterial pneumonia and other respiratory infections.
• Toyama owns exclusive development and commercialization rights to solithromycin in Japan. Cempra has received $40M in upfront and milestone payments to date from Toyama and can earn an additional $30M in milestones in addition to tiered royalties if solithromycin is approved for sale there.

¿Habemus rally?

Edito: me pueden las ganas, ver dos días verdes y ......

antes de la FED?

Pero alguien duda de la subida de tipos??

Me respondo, viendo Reino Unido, EEUU e Italia, igual nos sorprenden también.

No comprendo, la subida de tipos en Diciembre se da por si o si, no?

"La Fed, preparada para subir los tipos en diciembre"

https://www.google.es/amp/s/amp.expansion.com/mercados/2016/11/23/5835eb8a22601db9118b465d.html?client=safari

http://m.europapress.es/economia/finanzas-00340/noticia-yellen-fed-sugiere-subida-tipos-interes-eeuu-relativamente-pronto-20161117145615.html

https://www.google.es/amp/www.elconfidencial.com/amp/economia/2016-12-02/tasa-paro-estados-unidos-noviembre-2016_1298818/